InflaRx
Price & Volume
Stats
See more52W Range | $0.71-$2.94 |
Market Cap | $186.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $29,331 |
Revenue Growth (YoY) | -80.8% |
Gross Profit (12 Mos) | -$7.2M |
Diluted EPS | -$0.74 |
News
See moreYahoo Finance • 4 days ago
InflaRx N.V. (IFRX) Regains Compliance With Nasdaq
Yahoo Finance • last month
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization
Yahoo Finance • 2 months ago
InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting
Yahoo Finance • 2 months ago
InflaRx receives Nasdaq notification
About
CEO | Prof. Niels C. Riedemann M.D., Ph.D. |
Address | Winzerlaer Str. 2, Jena, Germany, 07745 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 65 |